KR20090010671A - The stability technology of using the technology of nano spherical particles including perfluorodecalin & perfluorobutyl ether which are oxygen carriers and the components of cosmetics including the nano spherical particles and the method of manufacturing the components - Google Patents
The stability technology of using the technology of nano spherical particles including perfluorodecalin & perfluorobutyl ether which are oxygen carriers and the components of cosmetics including the nano spherical particles and the method of manufacturing the components Download PDFInfo
- Publication number
- KR20090010671A KR20090010671A KR1020070073979A KR20070073979A KR20090010671A KR 20090010671 A KR20090010671 A KR 20090010671A KR 1020070073979 A KR1020070073979 A KR 1020070073979A KR 20070073979 A KR20070073979 A KR 20070073979A KR 20090010671 A KR20090010671 A KR 20090010671A
- Authority
- KR
- South Korea
- Prior art keywords
- purple
- ether
- composition
- perfluorobutyl ether
- cosmetic composition
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
- A61K8/70—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine containing perfluoro groups, e.g. perfluoroethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
According to the present invention, there is provided a stabilization technique using a microsphere method of perfluorodecarine and perfluorobutyl ether, which are oxygen transfer materials, and a cosmetic composition containing the same, and a method for preparing the same , wherein the cosmetic composition of the present invention is a total composition. Microspheres consisting of 0.1-10.0% by weight of poloxamer 188, 0.1-60.0% of perfluorodecarin by weight of the total composition and 0.1-60.0% of perfluorobutyl ether by weight of the composition, of the total weight of the composition Glycerin as an emulsion stability aid of 0.1% -20.0% is contained.
The cosmetic composition as described above can maintain purple orodercane and purple orobutyl ether stably for a long period of time without loss of activity or alteration, and has excellent affinity with the skin, so purple ordecaline and purple orobutyl ether It can fully exhibit the skin beauty effect by.
Description
Figure 1 shows the increase in the partial pressure of oxygen in the skin with increasing purple ordecaline (3.2, 4.8, 6, 8, 10%) (International Journal of Cosmetic Science, 18 137-150 (1996)).
Figure 2 compares the change in wrinkle depth of unapplied and applied products of purple orodecarin.
3 shows the solubility of perfluorobutyl ether in oxygen (ml / 100ml) at room temperature and 1 atmosphere.
4 shows the main part of the High Pressure Homogenizer.
The present invention relates to a stabilization technique using a microsphere method of perfluorodecarine and perfluorobutyl ether, which is an oxygen transfer material, and a cosmetic composition containing the same and a manufacturing method thereof .
In recent years, interest in functional cosmetics containing specific bioactive substances for the purpose of delaying skin aging, etc. has been increasing and many studies have been conducted. The present invention also relates to such a functional cosmetics is a cosmetic composition containing perfluorodecarin and perfluorobutyl ether having a function to increase the oxygen partial pressure of the skin . Purple aurodekarin and purple aobutyl ether blended in the cosmetic composition of the present invention is an oxygen carrier to increase the oxygen partial pressure of the skin lowered due to environmental factors such as ageing or smoking, thereby supplying oxygen to the skin. Aging delay function.
In order to apply the oxygen transport function of the purple orode carin and purple orobutyl ether to the cosmetics, cosmetics in which purple ordecarin or purple orobutyl ether is added to the cosmetics have been limited. However, conventional cosmetics are simple emulsified or gel type products prepared by simply adding purple orodecarine or purple orobutyl ether to the cosmetic composition. It is difficult to formulate, and has a drawback that there is a limit in application and separation in the preservation of perfluorodecarin or perfluorobutyl ether cosmetics contained in the cosmetic. The reason is generally the proportion of the cosmetic is 1.00 and out, but the proportion of decalin Oro perfluoroalkyl is 1.917, and the segregation or the precipitation occurs also haebomyeon observe the long-term stability to the proportion of purple Le oro-butyl ether is applied to more than 1.40 then the cosmetic It is difficult to apply the proper amount.
On the other hand, cosmetics of the drug delivery system (DD S method) recently used in pharmaceuticals have been proposed. In the case of liposome cosmetics, liposomes are required to be hydrophilic or lipophilic, so that appropriate liposomes are required for liposomes. There was a problem that must be selected.
Under such circumstances, the present inventors earnestly studied to provide a composition of perfluorodecarine and perfluorobutyl ether- containing cosmetics which do not have the above-mentioned problems and have excellent skin penetration and can be stably preserved without losing long-term activity. Results It has been found that the above object can be achieved by making microspheres of purple orodecarine and purple orobutyl ether added to cosmetics, and have completed the present invention.
That is, an object of the present invention is 0.1-10.0% of poloxamer 188 of the total composition weight, 0.1-60.0% of perfluorodecarinine of the total composition weight and 0.1-60.0% of perfluorobutyl ether of the total weight of the composition ( It is to provide a perfluorodecarine and perfluorobutyl ether- containing cosmetic composition, characterized in that it contains microspheres consisting of Perfluorobutyl ether) .
Still another object of the present invention is to pass a mixture containing purified water, poloxamer 188, perfluorodecarine and perfluorobutyl ether through a high pressure homogenizer to perfluorodecarine and perfluorobutyl. It is to provide a method for producing a cosmetic composition in which the ether- containing microspheres are evenly dispersed.
Hereinafter, the present invention will be described in more detail.
Since the cosmetic composition provided according to the present invention contains microencapsulated perfluorodecarine and perfluorobutyl ether, the percutaneous absorption of perfluorodecarine and perfluorobutyl ether is very excellent, and perfluorodecarin and It can be stably stored for a long time without losing the activity of perfluorobutyl ether .
Poloxamer 188 is used as a material for forming micelles containing perfluorodecarine and perfluorobutyl ether in contact with perfluorodecarine and perfluorobutyl ether to be encapsulated in the present invention. Used in amounts of 0.1% -10.0% by weight of the total.
The perfluorodecarin used in the present invention is used in an amount of 0.1-60.0% based on the total weight of the composition, and the perfluoropolybutyl ether is used in an amount of 0.1-60.0% based on the total weight of the composition.
The cosmetic composition of the present invention may contain an emulsification stabilizer to stabilize the perfluorodecarin and perfluorobutyl ether , and for example, polymers such as glycerin, and natural polymer compounds may be added in an amount of 0.1-to the total weight of the composition. It can be used in an amount of 20.0%.
According to the method of the present invention, first, purified water, poloxamer 188 is stirred with a homomixer, and the temperature is maintained at about 80 degrees to form a homogeneous aqueous solution. Meanwhile, a mixture of perfluorodecarin and perfluorobutyl ether is prepared and slowly added to the previously prepared aqueous solution to obtain an emulsion. The obtained emulsion is passed through a high pressure homogenizer to obtain an emulsion in which microspheres containing perfluorodecarin and perfluorobutyl ether are evenly dispersed.
According to the method of the present invention as described above, purple ordeoderine and purple orobutyl ether, which have been used in conventional medicines, are stabilized and blended into cosmetics without loss of activity, and improve permeability when applied to skin. It has become possible to provide an emulsion type cosmetic that can sufficiently exhibit the oxygen transport function possessed by decalin and perfluoroether .
Hereinafter, the present invention will be described in more detail with reference to the following Examples, but the present invention is not limited to these Examples.
Table 1. Example 1 and Comparative Example 1
Manufacturing method
Example 1: The
Comparative Example 1 The
Table 2. Example 2 and Comparative Example 2
Manufacturing method
Example 2
Comparative Example 2 The
Table 3. Example 3 and Comparative Example 3
Manufacturing method
Example 3: The
Comparative Example 3 The
Table 4. Example 4 and Comparative Example 4
Manufacturing method
Example 4 The
Comparative Example 4 The
[Centrifuge Stability Test]
In order to determine the centrifugation stability of the products manufactured according to the above examples and comparative examples, 500g of each product was prepared and taken in an appropriate amount, followed by centrifugation at 10 minutes at 4000 RPM, 10 minutes at 8000 RPM, and 10 minutes at 12000 RPM. The results obtained are shown in the table.
Table 5. Centrifuge Stability Test Results
As can be seen from the results of the centrifugation stability test of the table, Examples 1, 2, 3, and 4 containing a cosmetic composition stabilized with fluorine compounds using microspheres are comparative examples containing fluorine compounds by general emulsification. It was confirmed that there is no problem in the centrifugation stability compared to 1,2,3 and 4.
Using the raw material prepared in the above Example was prepared in the same manner as in the formulation example below.
Prescription Example 1.
Prescription examples of skin lotions in cosmetics containing purple aurodecalin and purple aurobutyl ether microspheres are as follows. Here, purple ordecaline and purple orobutyl ether microspheres are those of Example 1.
Table 6. Prescription example of skin lotion according to the present invention
Manufacturing method
Formulation Example 1:
Comparative Example 1:
Prescription Example 2.
Prescription examples of nutritional lotions in cosmetics containing purple orode carin and purple orobutyl ether microspheres are as follows. Here, the perfluorodecarine and the perfluorobutyl ether microspheres are those of Example 1.
Table 7. Prescription example of nutrition lotion according to the present invention
Manufacturing method
Formulation Example 2: The
Comparative Formulation Example 2: The
Prescription Example 3
Prescription examples of nutritional creams in cosmetics containing purple orodecarin and purple orobutyl ether microspheres are as follows. Here, purple ordecaline and purple orobutyl ether microspheres are those of Example 1.
Table 8. Prescription example of nutrition cream according to the present invention
Manufacturing method
Formulation Example 3:
Comparative Formulation Example 3 The
Prescription Example 4.
The prescription of the massage cream in cosmetics containing purple orodecarine and purple orobutyl ether microspheres is as follows. Here, purple ordecaline and purple orobutyl ether microspheres are those of Example 1.
Table 9. Prescription example of massage cream according to the present invention
Manufacturing method
Formulation Example 4: The
Comparative Formulation Example 4: The
Prescription Example 5.
Prescription examples of nutritional essences in cosmetics containing purple aurodecalin and purple aurobutyl ether microspheres are as follows. Here, the perfluorodecarine and the perfluorobutyl ether microspheres are those of Example 1.
Table 10. Prescription Examples of Nutritional Essences According to the Present Invention
Manufacturing method
Formulation Example 5: The
Comparative Formulation Example 5: The
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070073979A KR20090010671A (en) | 2007-07-24 | 2007-07-24 | The stability technology of using the technology of nano spherical particles including perfluorodecalin & perfluorobutyl ether which are oxygen carriers and the components of cosmetics including the nano spherical particles and the method of manufacturing the components |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070073979A KR20090010671A (en) | 2007-07-24 | 2007-07-24 | The stability technology of using the technology of nano spherical particles including perfluorodecalin & perfluorobutyl ether which are oxygen carriers and the components of cosmetics including the nano spherical particles and the method of manufacturing the components |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20090010671A true KR20090010671A (en) | 2009-01-30 |
Family
ID=40489813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070073979A KR20090010671A (en) | 2007-07-24 | 2007-07-24 | The stability technology of using the technology of nano spherical particles including perfluorodecalin & perfluorobutyl ether which are oxygen carriers and the components of cosmetics including the nano spherical particles and the method of manufacturing the components |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20090010671A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101706633B1 (en) * | 2016-08-25 | 2017-02-16 | 주식회사 엘라코리아 | Manufacturing method of cosmetic containing perfluorocarbon compounds |
-
2007
- 2007-07-24 KR KR1020070073979A patent/KR20090010671A/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101706633B1 (en) * | 2016-08-25 | 2017-02-16 | 주식회사 엘라코리아 | Manufacturing method of cosmetic containing perfluorocarbon compounds |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1740148B1 (en) | Low molecular weight silicone oil-in-water emulsion | |
EP2727580B1 (en) | Astaxanthin-containing composition, method for manufacturing same, and cosmetic | |
KR100874877B1 (en) | Oil-in-water-in-oil reversed-phase multi-emulsion phase using polyol-in-oil high density nano-concentrated emulsion, and preparation method thereof | |
JP5393123B2 (en) | External preparation for skin and method for producing the same | |
KR20210037647A (en) | Nano-emulsion cosmetic composition stabilized oil of high content | |
JP2002538947A (en) | Method for preparing cosmetic or pharmaceutical formulations using a micromixer | |
CN1845720B (en) | Concentrated and diluted stable oil/water emulsions | |
WO2015136778A1 (en) | Method for producing ceramide dispersion composition | |
JP2023160936A (en) | Composition for stabilizing poorly soluble ingredients and cosmetic composition comprising the same | |
CN104168877B (en) | Aqueous dispersed composition | |
JP6356446B2 (en) | Ceramide dispersion composition | |
KR20070080062A (en) | The stability technology of using the technology of the liposome including botanical extract which is effective for anti-acne and the components of cosmetics including the liposome and the method of manufacturing the components | |
KR100670440B1 (en) | The stability technology of using the technology of the liposome including adenosine & oil soluble licorice extract and the components of cosmetics including the liposome and the method of manufacturing the components | |
JPH08283303A (en) | Emulsifier comprising higher fatty acid dextrin, emulsion composition containing the same, and cosmetic | |
CN104379122B (en) | Cosmetics and emulsification composition containing Enoxolone derivative | |
JP2011046701A (en) | Emulsifier, dispersion stabilizer, and skin care preparation containing them | |
KR100737101B1 (en) | The stability technology of using the technology of the liposome including adenosine which is effective for anti-wrinkle and the components of cosmetics including the liposome and the method of manufacturing the components | |
KR20090010671A (en) | The stability technology of using the technology of nano spherical particles including perfluorodecalin & perfluorobutyl ether which are oxygen carriers and the components of cosmetics including the nano spherical particles and the method of manufacturing the components | |
KR19990084930A (en) | Cosmetic liquid composition comprising a multi-liquid crystal film capsule for cosmetics and a method of manufacturing the same and a multi-liquid crystal film capsule | |
KR100522311B1 (en) | The stability technology of using the technology of nano spherical particles including perfluorodecalin which is effective for anti-wrinkle and the components of cosmetics including the nano spherical particles and the method of manufacturing the components. | |
JP6480839B2 (en) | Ceramide dispersion composition | |
KR20070118061A (en) | The components of cosmetics including oxygen carriers and the method of manufacturing the components | |
JP2013095717A (en) | Skin care external preparation, oil-in-water emulsion composition, and skin care external preparation containing the same | |
KR20090040517A (en) | The components of cosmetics with the liposome including botanical extract which is effective for anti-acne and the method of manufacturing the components | |
JP2017171632A (en) | Cosmetic raw material and skin external preparation composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |